Generics 204

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Levocetirizine dihydrochloride manufacturers

204 products found

Filters

Filters

Filters , active

Country of origin : Russian-federation

Clear all

204 products found

levocetirizine dihydrochloride

Tablets, film coated 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

levocetirizine dihydrochloride

Tablets, film coated 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Czech Republic
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 22 days

levocetirizine dihydrochloride

Oral solution 0.5 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Czech Republic
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 22 days

Want to see all 204 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Levocetirizine dihydrochlorideManufacturers

Markets of interest

Levocetirizine dihydrochloride is is a selective histamine H1 antagonist prescribed to treat a variety of allergic symptoms. Levocetirizine has a greater affinity for the histamine H1 receptor than cetirizine. The substance is available for sale in the form of oral solution, tablets, tablets, film-coated, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Levocetirizine dihydrochloride suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Levocetirizine dihydrochloride manufacturers and distributors are based in China and North Korea.

Licensing and brand names

Levocetirizine dihydrochloride was approved for use in the United States in 1995. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Levocetirizine Dihydrochloride, Xyzal. One of the most popular branded versions of Levocetirizine dihydrochloride is manufactured and supplied by the Chinese pharmaceutical company Ningbo distant chemicals co.,ltd. Other manufacturing companies and distributors from European Union, India, United States, Turkey have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Levocetirizine dihydrochloride as an active ingredient.

Target supply price

The wholesale acquisition cost of the substance in the United States depending on the amount of drug in the pack ranges between $15 and $25. The retail price of Levocetirizine dihydrochloride depending on the concentration of the substance in a tablet and pack size can reach up to 25 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Levocetirizine dihydrochloride manufacturers and suppliers that you are looking for. You can also find the dossier status of Levocetirizine dihydrochloride and the GMP approvals of the different variants of the medication. The product description of all Levocetirizine dihydrochloride suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Levocetirizine dihydrochloride is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation